Question

I am a breastfeeding mother and i want to know if it is safe to use EINECS 249-577-2? Is EINECS 249-577-2 safe for nursing mother and child? Does EINECS 249-577-2 extracts into breast milk? Does EINECS 249-577-2 has any long term or short term side effects on infants? Can EINECS 249-577-2 influence milk supply or can EINECS 249-577-2 decrease milk supply in lactating mothers?

EINECS 249-577-2 lactation summary

EINECS 249-577-2 is safe in breastfeeding
  • DrLact safety Score for EINECS 249-577-2 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of EINECS 249-577-2 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that EINECS 249-577-2 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of EINECS 249-577-2 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About EINECS 249-577-2 usage in lactation

Antifungal agent that is used as a component of creams, gels, suspensions or pessaries. At latest update no published data were found on excretion into breast milk. Less than 5% of the applied dose is absorbed.Because the small dose used and low level achieved in the plasma of most topical dermatological preparations make unlikely the passage of significant amounts into breast milk.Even more, its high plasma protein-binding capacity makes unlikely excretion into milk. Do not apply on the chest to prevent infant ingestion; otherwise, apply it after a feeding and clean thoroughly with water before the next one.

Answer by DrLact: About EINECS 249-577-2 usage in lactation

Topical EINECS 249-577-2 has not been studied during breastfeeding. Because only about 1.3% is absorbed after topical application, it is considered a low risk to the nursing infant.[1] Avoid application to the nipple area and ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated. Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.[2]

Alternate Drugs

Nelfinavir(Unsafe)
Linezolid(Low Risk)
Lomefloxacin(Low Risk)
Cefaclor(Safe)
Clindamycin(Low Risk)
Levofloxacin(Low Risk)
Kanamycin(Safe)
Dapsone(Low Risk)
Econazole(Safe)
Amantadine(Low Risk)
Indinavir(Unsafe)
Naftifine(Safe)
Capreomycin(Low Risk)
Acyclovir(Safe)
Aztreonam(Safe)
Cefprozil(Safe)
Ertapenem(Safe)
Quinine(Safe)
Rifaximin(Safe)
Zidovudine(Low Risk)
Cefoxitin(Safe)
Gatifloxacin(Low Risk)
Ofloxacin(Safe)
Cefotetan(Safe)
Tenofovir(Safe)
Enoxacin(Low Risk)
Efavirenz(Unsafe)
Doxycycline(Low Risk)
Amikacin(Safe)
Didanosine(Unsafe)
Neomycin(Safe)
Nafcillin(Safe)
Lindane(Unsafe)
Cefixime(Safe)
Saquinavir(Unsafe)
Demeclocycline(Low Risk)
Moxifloxacin(Low Risk)
Cefepime(Safe)
Valganciclovir(Low Risk)
Ritonavir(Unsafe)
Ganciclovir(Low Risk)
Abacavir(Safe)
Methicillin(Low Risk)
Cefdinir(Safe)
Primaquine(Low Risk)
Famciclovir(Low Risk)
Meropenem(Safe)
Malathion(Low Risk)
Cefazolin(Safe)
Nevirapine(Low Risk)
Atovaquone(Low Risk)
Erythromycin(Low Risk)
Amphotericin B(Low Risk)
Naftifine(Safe)
Econazole(Safe)
Nystatin(Safe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.